secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001193125-24-130779
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics adopts limited-duration poison pill after recent stock accumulations
--------------------------------------------------------------------------------

- Board adopted Rights Agreement effective May 2, 2024, responding to recent accumulations of common stock.
- Each outstanding common share receives one right; triggers at 10% beneficial ownership without Board approval.
- Upon trigger, rights holders (except acquirer) can buy shares at 50% discount; rights expire May 2, 2025.
- Record date for dividend of rights is May 20, 2024; exercise price $1.50 per right.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524130779/0001193125-24-130779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524130779/d835891d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-130779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer